Astrazeneca Plc

AZN chart

Astrazeneca Plc news

• Breast Cancer Canada and AstraZeneca Canada Advance Next-Generation Survivorship Research

  Morningstar · Oct 27, 2:40 PM EDT

• EU Approves Daiichi Sankyo and AstraZeneca’s Enhertu for Early HER2-Positive Breast Cancer

  BioPharma APAC · Oct 27, 2:34 PM EDT

• AstraZeneca may start work on cancer vaccines, CEO says

  Yahoo Finance · Oct 27, 1:57 PM EDT

• AstraZeneca mulls cancer vaccine development (AZN:NYSE)

  Seeking Alpha · Oct 27, 1:57 PM EDT

• AstraZeneca might develop cancer vaccines, CEO Pascal Soriot says

  Quartz · Oct 27, 1:17 PM EDT

• AstraZeneca May Enter Cancer Vaccine Development, CEO Says

  Bloomberg.com · Oct 27, 12:44 PM EDT

• AstraZeneca and Daiichi Sankyo’s Enhertu Gets EU Nod for Residual Treatment in HER2+ Early Breast Cancer

  Contract Pharma · Oct 27, 11:51 AM EDT

• AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over

  Pharmafile · Oct 27, 11:02 AM EDT

• Tremont AI Announces New Research Collaboration to Develop AI Models for Preclinical Safety Assessment

  Yahoo Finance · Oct 27, 11:00 AM EDT

• AstraZeneca offers compelling risk-reward into 2027 pipeline readouts, says JPMorgan

  proactiveinvestors.com · Oct 27, 10:30 AM EDT

• A Quick Look at Today's Ratings for AstraZeneca(AZN.US), With a Forecast Between $193.43 to $233.45

  Moomoo · Oct 27, 9:34 AM EDT

• Enhertu Wins EU Approval After 53% Lower Recurrence Risk

  grafa.com · Oct 27, 8:35 AM EDT

Astrazeneca Plc key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KENHERTU APPROVED IN EU FOR HER2-POSITIVE EBC2026-10-27
• 6-KULTOMIRIS APPROVED IN US IN IGAN2026-10-22
• 6-KASTRAZENECA COMPLETES EQUITY INVESTMENT IN SUMMIT2026-10-05
• 6-KAZ & DS COLLABORATION WITH SUMMIT FOR DATROWAY2026-10-02
• 6-KADMISSION OF FURTHER SECURITIES TO TRADING2026-10-01
• 6-KTOTAL VOTING RIGHTS2026-10-01
• 6-KASTRAZENECA ANNOUNCES EQUITY INVESTMENT IN SUMMIT2026-09-29
• 6-KTRIXEO APPROVED IN EU FOR ASTHMA2026-09-23
• 6-KKLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP2026-09-21
• 6-KENHERTU RECOMMENDED FOR APPROVAL IN EU IN EARLY BC2026-09-21
• 6-KDIRECTOR/PDMR SHAREHOLDING2026-09-18
• 6-KDIRECTOR/PDMR SHAREHOLDING2026-09-15

About Astrazeneca Plc

Ticker

AZN (NYSE)

Industry

Pharmaceutical Preparations

Headquarters

Cambridge

Incorporated in

United Kingdom

Fiscal year end

December 31

SEC CIK

901832

Former names

ZENECA GROUP PLC

Frequently asked questions